@article{JTD25551,
author = {Christos Fountzilas and Steven N. Hochwald},
title = {Immune checkpoint inhibitors in esophagogastric cancer: still a long way to go},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {2},
year = {2018},
keywords = {},
abstract = {Immune checkpoint inhibitors (ICIs) targeting the programmed death 1/programmed death-ligand 1 (PD1/PD-L1) pathway have revolutionized treatment for various cancers. Evasion of the immune system is one of the hallmarks of cancer and chronic inflammation can facilitate cancer progression.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/25551}
}